Esperion Therapeutics Inc (NASDAQ:ESPR)

113.77
Delayed Data
As of May 21
 -1.34 / -1.16%
Today’s Change
13.90
Today|||52-Week Range
120.96
+181.33%
Year-to-Date

Today’s Trading

Previous close115.11
Today’s open117.51
Day’s range-- - --
Volume1,064,378
Average volume (3 months)980,406
Market cap$2.6B
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)+32.93%
Earnings growth (this year)-8.74%
Earnings growth (next 5 years)-21.89%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book17.53

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc+0.02+0.23%
KITEKite Pharma Inc+0.32+0.62%
HALOHalozyme Therapeutic...+0.40+2.37%
RDUSRadius Health Inc-0.27-0.56%
Data as of 05/21/2015

Financials

Last reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$0.00
Annual profit (last year)-$36.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Scientific Officer
Roger S. Newton
President, Chief Executive Officer &
Director
Tim M. Mayleben
Corporate headquarters
Ann Arbor, Michigan

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers